Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2004
12/01/2004EP1481971A1 Process for producing 4-aminoquinazoline compound
12/01/2004EP1481965A1 Aromatic amino acid derivatives and medicinal compositions
12/01/2004EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004EP1480980A2 Syntheses of quinazolinones
12/01/2004EP1480959A1 Piperazine derivatives as anti-inflammatory agents
12/01/2004EP1480958A1 Uracil-thioether
12/01/2004EP1480957A1 Hppars activators
12/01/2004EP1480679A1 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
12/01/2004EP1480650A1 Novel crystalline forms of the anti-cancer compound zd1839
12/01/2004EP1366026B1 Pyrimidine compounds and their use as pesticides
12/01/2004EP1357889A4 Novels couplers for use in oxidative hair dyeing
12/01/2004EP1181280B1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
12/01/2004EP1175408B1 Pyrimidinone compounds
12/01/2004EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004CN1550232A Use of heterocyclic amide in production of autoimmune diseases inhibitors
12/01/2004CN1177848C Bicyclic heteroaromatic compounds useful as LH agonists
12/01/2004CN1177835C Substituted benzoylcyclohexandiones
12/01/2004CN1177833C Substd. quinazoline derivatives
12/01/2004CN1177832C Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
11/2004
11/30/2004US6825199 7-Substituted quinazolin-2,4-diones useful as antibacterial agents
11/30/2004US6825198 5-HT receptor ligands and uses thereof
11/30/2004US6825183 Substituted benzoylcyclohexanediones for use as herbicides
11/30/2004CA2251795C Novel n-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands
11/30/2004CA2075189C Method and compositions for the synthesis of bch-189 and related compounds
11/25/2004WO2004101529A1 Nitrogenous heterocyclic compound and medical use thereof
11/25/2004WO2004085385A3 Cannabinoid receptor ligands
11/25/2004WO2004084842A3 Inhibitors of cathepsin s
11/25/2004WO2004062609A3 Pyrimidine derivatives as il-8 receptor antagonists
11/25/2004US20040236147 Integrin antagonist; antiinflammatory agents; antiarthritic agents; inflammatory bowel disease; lupus; multiple sclerosis; asthma; psoriasis;antidiabetic agents; cardiovascular disorders
11/25/2004US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004US20040235908 Treating an a-chemokine mediated disease; melanoma, gastric carcinoma, and non-small cell lung cancer, gingivitis, respiratory viruses, herpes viruses, hepatitis viruses, HIV, kaposi's sarcoma associated virus and atherosclerosis
11/25/2004US20040235877 Novel use of tricyclic compound
11/25/2004US20040235876 4,5-Disubstituted-2-aminopyrimidines
11/25/2004US20040235870 Protein kinase inhibitors
11/25/2004US20040235848 Phenylalanine derivatives
11/25/2004US20040235846 Administering substituted nicotinamides and nicotinamide analogs for therapy of disorder responsive to the induction of apoptosis in an animal; anti-cancer agents
11/25/2004US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004US20040235823 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor
11/25/2004US20040235666 Substituted imidates as pesticidal agents
11/25/2004US20040235661 Herbicide composition
11/25/2004US20040231557 Red pigments formed by diazotization of aromatic amines then coupling to 1-methyl-6-(2'-hydroxy-3'-naphthoylamino)-quinazoline-2,4-dione, used in varnishes, plastics, inks, toners, developers, coatings or color filters.
11/25/2004CA2526086A1 Heterocyclic compounds
11/24/2004EP1479671A1 Pyrimidinone compounds
11/24/2004EP1478620A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/24/2004EP1478613A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benz[a]anthracenes for selective effects on estrogen receptors
11/24/2004EP1478364A2 Selective antibacterial agents
11/24/2004EP1322168B1 Stabilised compositions having antibacterial activity
11/24/2004EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
11/24/2004EP0929538B1 O?2 -arylated or o?2 -glycosylated 1-substituted diazen-1-ium-1,2-diolates and o?2 -substituted 1- (2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
11/24/2004CN1549813A Pyrimidineamines as angiogenesis modulators
11/24/2004CN1549808A New mandelic acid derivatives and their use as thrombin inhibitors
11/24/2004CN1549717A Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, process for producing them and pharmaceutical compositions containing them
11/24/2004CN1176922C 8-quinolinxanthine and 8-isoquinolinxanthine derivs. as PDE 5 inhibitors
11/24/2004CN1176913C Potassium chlorobromo isocyanurate and its production process and application
11/24/2004CN1176912C Process for preparing 2-methyl-4-amino-5-amino methylpyrimidine
11/23/2004US6822095 Chlorination of 4-chloro-6-hydroxypyrimidine with an acid chloride
11/23/2004US6821980 Substituted 5-benzyl-2,4-diaminopyrimidines
11/23/2004US6821967 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9h-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
11/23/2004US6821927 Hydroxamic acid derivatives
11/23/2004US6821582 Positive dielectric anisotropy
11/23/2004CA2347280C Novel process for the preparation of nucleotides
11/23/2004CA2111662C Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease
11/18/2004WO2004099171A2 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004WO2004099160A1 Pyrimidine compounds and pests controlling composition containing the same
11/18/2004WO2004099159A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
11/18/2004WO2004099148A1 Substituted pyrimidine derivatives
11/18/2004WO2004078109A3 PROCESS FOR SYNTHESISING USEFUL INTERMEDIATES FOR THE PREPARATION OF ανβ3 RECEPTOR ANTAGONISTS
11/18/2004US20040229955 Antibacterial agents
11/18/2004US20040229922 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
11/18/2004US20040229910 Therapeutic compounds
11/18/2004US20040229905 Preparation of risperidone
11/18/2004US20040229892 HIV integrase inhibitors
11/18/2004US20040229891 For therapy of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
11/18/2004US20040229889 HDAC inhibitor
11/18/2004US20040229870 Certain alkylene diamine-substituted heterocycles
11/18/2004DE10319612A1 Substituierte Dihydrochinazoline Substituted dihydroquinazolines
11/18/2004CA2524352A1 Substituted pyrimidine derivatives
11/18/2004CA2524221A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
11/18/2004CA2523718A1 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/17/2004EP1477482A1 Novel phenylalanine derivative
11/17/2004EP1477481A1 Process for producing quinazolin-4-one derivative
11/17/2004EP1476753A2 Functionalized compositions for improved immobilization
11/17/2004EP1476436A1 Method for producing 2-anilino-4,6-dimethylpyrimidine
11/17/2004EP1476435A1 Novel pyridin- and pyrimidin-derivatives
11/17/2004EP1476423A2 Arylsulfonamidobenzylic compounds
11/17/2004EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004EP1476165A1 Substituted pyrimidinones and pyrimidinthiones
11/17/2004EP1165560B1 2-hydroxy methylcyclopro pylidenemethyl purines as antiviral agents
11/17/2004EP1156999B1 Method for the preparation of a chiral-beta-amino ester
11/17/2004EP1087953B1 Nitrate salts of antihypertensive medicines
11/17/2004EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/17/2004EP0679160B1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
11/17/2004CN1547672A Ultrasonic doppler effect speed measurement
11/16/2004US6818659 Targets and binds biological receptors; medical diagnosis; magnetic resonance, x-ray, ultrasound, and contrast imaging
11/16/2004US6818648 Psychological disorders; anxiolytic agents; antidepressants; eating disorders; alcoholism; drug abuse; antiinflammatory agents
11/16/2004US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
11/16/2004US6818644 Fluorene-9-carboxylic amides; inhibitors of microsomal triglyseride-transfer protein (mtp); antilipemic agents; atherosclerosis, diabetes, eating disorders, and pancreatitis
11/16/2004US6818641 Arthropodicidal carboxanilides
11/16/2004US6818635 For therapy of bacterial infections and neoplasms,